image

The best stocks to buy since 1993

Latest issue now available

Spire - 3 directors buy 235,000 shares after fall

September 2018

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • SPI
  • Price:
  • 172p
Bears have been having a field day at hospital chain Spire (SPI; 172p) with the share price seeing an extended fall last month. Softer demand from the NHS has come after a crooked surgeon was jailed for giving patients unnecessary breast operations, resulting in a fine to Spire even though it had suspended the surgeon in 2011. Three directors have been buying heavily in the last month (a combined 235,000 at c.160p) and with would-be-predator Mediclinic (MDC; 489p) sitting in the wings with a 29.9% stake for which it paid 360p in 2016, the shares are worth buying on weakness. Results are due on 18 September and could herald a recovery.Spire is the second largest national hospital chain in the UK behind HCA. The business was formed f ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

author

LIMITED PERIOD OFFER

SUBSCRIBE TODAY AND SAVE £40 WITH OFFER CODE 40OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe